Jay Wei founded Optovue, Inc., in 2003 to develop the next generation of Ophthalmic OCT instruments. His vision in the clinical use of OCT technology has resulted in the first FDA cleared Fourier-domain (spectral domain) OCT system, RTVue®. Jay has been working in ophthalmic instrument development and management since 1992, and he has pioneered the commercialization of optical coherence technology for ophthalmic diagnosis since 1994.
Prior to founding Optovue, Jay was a Director of Advanced Development and an OCT Program Manager at Carl Zeiss Meditec (Humphrey Instruments). He led the OCT development from ground zero in 1993 and delivered all prior generations of OCT products to the market.
Jay received his Bachelor of Science in Electro-physics from the National Chiao-Tung University in Taiwan, and a Master of Science in Applied Optics from the University of New Mexico. He has been granted over 30 patents in ophthalmic devices and has published research in over 10 peer-reviewed journals.
David joined Optovue in February 2012 as Chief Financial Officer and was promoted to President and CFO in March 2013. Prior to this, he was the CFO at Cyntellect, where he provided financial leadership for the sale of that company’s LEAP and Celigo product lines in 2011. He was also CFO for SynergEyes and CFO for Laser Diagnostic Technologies until its sale to Carl Zeiss Meditec in December 2004.
David has also held positions in finance with Alaris Medical Systems and Metracor Technologies, and he began his career at Deloitte & Touche as a CPA.
David received his Bachelor of Arts in Business and Accounting from Arizona State University.
John Hawley joined the company in 2008 with more than 30 years of experience in ophthalmic diagnostic instrumentation, service, sales, marketing and strategic planning. Before joining Optovue, he was a Vice President for Heidelberg Engineering, where he was responsible for building its U.S. business over a 15-year period, growing annual sales from $500,000 to $28 million. Prior to this, John was a Regional Sales Manager for BioRad/INTERZEAG. He has also held management and manufacturing positions for Cilco.
John was a member of the Royal Australian Navy for eight years where he attained the rank of E6, First Class Petty Officer.
Judy joined Optovue in 2015, bringing over 25 years of global product launch, program marketing and product development experience in the medical device and healthcare industry. Prior to joining Optovue, Judy was Vice President of Marketing for Cervel Neurotech, Inc., an early stage neuromodulation company where she supported the business development and fundraising efforts. Before this, she was an independent consultant in the electrophysiology, interventional cardiology, radiation oncology and ultrasound industries, with clients that included BioVentrix, Hansen Medical, Calypso Medical, Edan Medical, Zonare, Thermedical and VytronUS.
Judy also served as Vice President of Marketing for Hansen Medical, Inc., where she supported the company’s initial public offering, established the marketing department and played a key role in the global launch of the Sensei™ Robotic Catheter System. Previously, she served as Director of Marketing at Siemens Medical (Acuson Corp).
Judy holds a Bachelor of Science in Nursing from California State University, Chico, and a Master of Business Administration from Santa Clara University.
Dr. Shaun Chen has over 15 years of experience in research and development, business strategy and clinical affairs in the medical device industry. He joined Optovue in 2015 as the senior director of marketing strategy, and was promoted to vice president of research and development in October 2017. Prior to joining Optovue, Dr. Chen was the director of business development for the medical division at Carl Zeiss in Shanghai. Before this, he was the manager of strategic sourcing and the China transfer project lead for Meditec at Carl Zeiss Suzhou Co. Dr. Chen has also held senior research and software development positions in his career at Carl Zeiss Meditec Inc., and Eaton Corporation.
Dr. Chen received a Bachelor of Engineering in Biomedical Instrumentation from Shanghai Jiao Tong University in China. He earned a Master of Science in Electrical Engineering and his Ph.D. in Biomedical Engineering from the University of Michigan at Ann Arbor.
Marshall joined Optovue in October 2013, bringing with him over 25 years of operations experience in medical device and biotechnology within the ophthalmology and cardiology segments. Prior to joining Optovue, Marshall was a Director of Operations at Topcon Medical Laser Systems, where he was responsible for all aspects of supply chain, manufacturing engineering, ERP system and manufacturing management. Before this, he was Director of Operations for OptiMedica, overseeing the supply chain, manufacturing, operational ERP systems and manufacturing engineering functions.
Additionally, Marshall was Director of Operations for IRIDEX, and he held materials management positions at both Baxter Healthcare and Coherent.
Marshall received his Bachelor of Arts in Economics from the University of California, Irvine, and a Master in Business Administration from National University.
Gordon joined Optovue in April 2009 with over 30 years of financial and operations experience with public and private companies in medical device, high technology, business-to-business Internet applications and biotechnology. Prior to joining Optovue, Gordon held the position of Vice President of Finance for Ink2, Consensus Orthopedics and IBM/Mylex. He also held senior finance positions at The Permanente Medical Group, Toshiba, Millipore and Litton/Applied Technology.
Gordon received a Bachelor of Science in Food Science from the University of California, Davis, and a Master of Business Administration from California State University, Hayward.
Dr. Qienyuan Zhou has 20 years of experience in the ophthalmic imaging device field, including research and development, software-based clinical applications development, clinical research, and device clinical validation. She joined Optovue in February 2010 where she is responsible for clinical affairs, clinical applications, and algorithm development.
Prior to her current position as Vice President of Clinical Affairs, she worked as Senior Director of Clinical Research. Before joining Optovue, she was Senior Manager of Advanced Development for Carl Zeiss Meditec, and prior to this, she held the position of Director of Research & Development for Laser Diagnostic Technologies, Inc.
Dr. Zhou holds a Bachelor of Science in Optical Engineering from Zhejiang University in Hangzhou, China, and a Ph.D. in Biomedical Engineering from the University of Miami. She has received multiple U.S. patents and served as principal investigator on multiple NIH SBIR grants.
Indu Joined Optovue in 2017, bringing with him more than 20 years of experience in quality and regulatory affairs in medical device and diagnostics. His executive management responsibilities have included quality assurance, regulatory affairs, clinical validations, quality system audits and U.S. Food & Drug Administration (FDA) inspections. Prior to joining Optovue, Indu was vice president of quality at Scanadu. Before this, he held senior management and engineering positions in quality and regulatory affairs for Roche Diagnostics, BioImagene, Boston Scientific, Keravision, Cybeq Nano Technologies, a subsidiary of Mitsubishi, and Sanmina.
Indu holds a Bachelor of Science in Engineering from the University of Mysore and a Master of Science in Engineering from Kansas State University.
Transform your view of ocular diseases — from the anterior segment to the choroid.Learn More
Transform your view of retinal vasculature.Learn More
Transform your eye exam.Learn More